Molecular signature of stem-like glioma cells (SLGCs) from human glioblastoma and gliosarcoma
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0291368 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Christina Zechel und 14 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Experimental Neuro-Oncology, Center of Brain, Behavior and Metabolism, University Lübeck, Lübeck, Germany. Hauptthemen laut MEDLINE: Glioblastoma, Gliosarcoma, Brain Neoplasms, Glioma. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Glioblastoma multiforme (GBM) and the GBM variant gliosarcoma (GS) are among the tumors with the highest morbidity and mortality, providing only palliation. Stem-like glioma cells (SLGCs) are involved in tumor initiation, progression, therapy resistance, and relapse. The identification of general features of SLGCs could contribute to the development of more efficient therapies. Commercially available protein arrays were used to determine the cell surface signature of eight SLGC lines from GBMs, one SLGC line obtained from a xenotransplanted GBM-derived SLGC line, and three SLGC lines from GSs. By means of non-negative matrix factorization expression metaprofiles were calculated. Using the cophenetic correlation coefficient (CCC) five metaprofiles (MPs) were identified, which are characterized by specific combinations of 7–12 factors. Furthermore, the expression of several factors, that are associated with GBM prognosis, GBM subtypes, SLGC differentiation stages, or neural identity was evaluated. The investigation encompassed 24 distinct SLGC lines, four of which were derived from xenotransplanted SLGCs, and included the SLGC lines characterized by the metaprofiles. It turned out that all SLGC lines expressed the epidermal growth factor EGFR and EGFR ligands, often in the presence of additional receptor tyrosine kinases. Moreover, all SLGC lines displayed a neural signature and the IDH1 wildtype, but differed in their p53 and PTEN status. Pearson Correlation analysis identified a positive association between the pluripotency factor Sox2 and the expression of FABP7, Musashi, CD133, GFAP, but not with MGMT or Hif1α. Spherical growth, however, was positively correlated with high levels of Hif1α, CDK4, PTEN, and PDGFRβ, whereas correlations with stemness factors or MGMT (MGMT expression and promoter methylation) were low or missing. Factors highly expressed by all SLGC lines, irrespective of their degree of stemness and growth behavior, are Cathepsin-D, CD99, EMMPRIN/CD147, Intβ1, the Galectins 3 and 3b, and N-Cadherin.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory of Experimental Neuro-Oncology, Center of Brain, Behavior and Metabolism, University Lübeck, Lübeck, Germany.
- Department of Neurosurgery, University Clinic Schleswig-Holstein, Campus Lübeck, Lübeck, Germany.
- Institute for Neuro- and Bioinformatics (INB), University Lübeck, Lübeck, Germany.
ORCID-Profile: Christina Zechel, Birga Soetje, Viktoria Willeke
Zitieren
APA
Zechel, C., Loy, M., Wegner, C., Dahlke, E., Soetje, B., Baehr, L., Leppert, J., Ostermaier, J. J., Lueg, T., Nielsen, J., Elßner, J., Willeke, V., Marzahl, S., Tronnier, V., & Madany Mamlouk, A. (2024). Molecular signature of stem-like glioma cells (SLGCs) from human glioblastoma and gliosarcoma. PLOS ONE. https://doi.org/10.1371/journal.pone.0291368
Vancouver
Zechel C, Loy M, Wegner C, Dahlke E, Soetje B, Baehr L, et al. Molecular signature of stem-like glioma cells (SLGCs) from human glioblastoma and gliosarcoma. PLOS ONE. 2024. doi:10.1371/journal.pone.0291368
BibTeX
@article{Zechel2024,
author = {Zechel, Christina and Loy, Mira and Wegner, Christiane and Dahlke, Eileen and Soetje, Birga and Baehr, Laura and Leppert, Jan and Ostermaier, Johannes J and Lueg, Thorben and Nielsen, Jana and Elßner, Julia and Willeke, Viktoria and Marzahl, Svenja and Tronnier, Volker and Madany Mamlouk, Amir},
title = {Molecular signature of stem-like glioma cells (SLGCs) from human glioblastoma and gliosarcoma},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0291368}
}
EUVIMED